TokenPost·
J&J’s JJDC Venture Arm Co-Leads Delix Therapeutics’ $100 Million Round
The financing will support Phase IIb proof-of-concept work for recurrent major depressive disorder and Delix’s broader neuroplastogen pipeline.
More news
- TokenPostRWA Perpetuals Post $829.4 Billion in October Trading Volume
- Crypto BriefingUS 10-year Treasury auction sees highest yield tail since February
- CoinGapeKazakhstan Central Bank Invests $190M in Crypto Funds and Bitcoin ETFs
- Crypto BriefingHighTower Advisors boosts Bitcoin spot ETF exposure by 50% in Q3
- TokenPostBitfinex Says Bitcoin Tracked Nasdaq Since Midterm Elections
- TokenPostARK Invest Transfers 265 Bitcoin Worth About $19.85 Million to Coinbase